| Primary |
| Product Used For Unknown Indication |
45.2% |
| Epilepsy |
22.2% |
| Depression |
4.8% |
| Drug Use For Unknown Indication |
3.3% |
| Bipolar Disorder |
3.0% |
| Convulsion |
2.6% |
| Drug Use For Unknown Indication |
2.2% |
| Schizophrenia |
2.2% |
| Schizoaffective Disorder |
1.9% |
| Bipolar Ii Disorder |
1.5% |
| Pyrexia |
1.5% |
| Salivary Hypersecretion |
1.5% |
| Accidental Exposure To Product By Child |
1.1% |
| Drooling |
1.1% |
| Grand Mal Convulsion |
1.1% |
| Myoclonic Epilepsy |
1.1% |
| Pruritus |
1.1% |
| Seizures |
1.1% |
| Epilepsy |
0.7% |
| Affective Disorder |
0.7% |
|
| Toxicity To Various Agents |
17.3% |
| Maternal Drugs Affecting Foetus |
9.3% |
| Weight Increased |
8.0% |
| Stevens-johnson Syndrome |
5.3% |
| Toxic Epidermal Necrolysis |
5.3% |
| White Blood Cell Count Increased |
5.3% |
| Drug Ineffective |
4.0% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
4.0% |
| Maternal Exposure During Pregnancy |
4.0% |
| Sensation Of Heaviness |
4.0% |
| Skin Exfoliation |
4.0% |
| Stress |
4.0% |
| Thrombocytopenia |
4.0% |
| Tremor |
4.0% |
| Vomiting |
4.0% |
| Brugada Syndrome |
2.7% |
| Drug Interaction |
2.7% |
| Epilepsy |
2.7% |
| Mood Swings |
2.7% |
| Periodontitis |
2.7% |
|
| Secondary |
| Product Used For Unknown Indication |
46.4% |
| Epilepsy |
16.7% |
| Temporal Lobe Epilepsy |
10.1% |
| Seizures |
7.1% |
| Bipolar Disorder |
5.4% |
| Depression |
3.0% |
| Status Epilepticus |
1.8% |
| Affective Disorder |
1.2% |
| Psychosis |
1.2% |
| Schizoaffective Disorder |
1.2% |
| Bipolar Disorder |
0.6% |
| Antidepressant Therapy |
0.6% |
| Bipolar Ii Disorder |
0.6% |
| Contraception |
0.6% |
| Convulsion |
0.6% |
| Depressed Mood |
0.6% |
| Drooling |
0.6% |
| Drug Use For Unknown Indication |
0.6% |
| Extrapyramidal Disorder |
0.6% |
| Grand Mal Convulsion |
0.6% |
|
| Toxicity To Various Agents |
33.3% |
| Epilepsy |
8.3% |
| Weight Increased |
8.3% |
| Suicide Attempt |
6.3% |
| Overdose |
4.2% |
| Poisoning |
4.2% |
| Rash |
4.2% |
| Ventricular Tachycardia |
4.2% |
| Weight Decreased |
4.2% |
| Accidental Poisoning |
2.1% |
| Convulsion |
2.1% |
| Drug Abuse |
2.1% |
| Drug Ineffective |
2.1% |
| Drug Resistance |
2.1% |
| Exposure Via Ingestion |
2.1% |
| Headache |
2.1% |
| Idiosyncratic Drug Reaction |
2.1% |
| Maternal Drugs Affecting Foetus |
2.1% |
| Oxygen Saturation Decreased |
2.1% |
| Patent Ductus Arteriosus |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.1% |
| Epilepsy |
11.1% |
| Multiple Sclerosis |
6.9% |
| Bipolar Disorder |
5.6% |
| Depression |
5.6% |
| Osteoporosis |
5.6% |
| Relapsing-remitting Multiple Sclerosis |
4.2% |
| Tuberous Sclerosis |
4.2% |
| Grand Mal Convulsion |
2.8% |
| Hypertension |
2.8% |
| Immunodeficiency Common Variable |
2.8% |
| High Cholesterol |
1.4% |
| Alcoholism |
1.4% |
| Antidepressant Therapy |
1.4% |
| Antiretroviral Therapy |
1.4% |
| Attention Deficit/hyperactivity Disorder |
1.4% |
| Bipolar I Disorder |
1.4% |
| Candida Infection |
1.4% |
| Complex Partial Seizures |
1.4% |
| Convulsion |
1.4% |
|
| Somnolence |
11.4% |
| Rash |
8.6% |
| Urinary Tract Infection |
8.6% |
| Vision Blurred |
8.6% |
| Fatigue |
5.7% |
| Nausea |
5.7% |
| Overdose |
5.7% |
| Renal Impairment |
5.7% |
| Toxicity To Various Agents |
5.7% |
| Tremor |
5.7% |
| Abdominal Discomfort |
2.9% |
| Aggression |
2.9% |
| Atrioventricular Block Complete |
2.9% |
| Blood Count Abnormal |
2.9% |
| Depressed Mood |
2.9% |
| Drug Interaction |
2.9% |
| Dyspnoea |
2.9% |
| Electroencephalogram Abnormal |
2.9% |
| Epiphysiolysis |
2.9% |
| Heart Rate Decreased |
2.9% |
|
